Concepedia

Philip D. Hall

PD

20

Publications

828

Citations

18

H-Index

1987

Active since

Affiliations

Medical University of South Carolina(Current)

Wake Forest University

National Institutes of Health

National Cancer Institute

MUSC Hollings Cancer Center

Philip D. Hall is an author at Medical University of South Carolina specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

1987–2010

20

Publications

20

Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia.

Arthur E. Frankel, Bayard L. Powell, Philip D. Hall et al. · PubMed · 2002 · 113 citations

Single‐Dose Rasburicase 6 mg in the Management of Tumor Lysis Syndrome in Adults

Anne McDonnell, Kristi L Lenz, Debra Frei‐Lahr et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2006 · 83 citations

Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE

John B. Bossaer, Philip D. Hall, Elizabeth Garrett‐Mayer · Supportive Care in Cancer · 2010 · 60 citations

, , +8

Interstitial Diphtheria Toxin-Epidermal Growth Factor Fusion Protein Therapy Produces Regressions of Subcutaneous Human Glioblastoma Multiforme Tumors in Athymic Nude Mice

Tie Fu Liu, Philip D. Hall, Kimberley A. Cohen et al. · Clinical Cancer Research · 2005 · 57 citations · Full text

Modulation of the Apoptotic Response of Human Myeloid Leukemia Cells to a Diphtheria Toxin Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein

Arthur E. Frankel, Philip D. Hall, Chris Burbage et al. · Blood · 1997 · 51 citations · Full text

Rows per page

1–5 of 20